Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
The Journal of Antimicrobial Chemotherapy
|
July 3, 2014
Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme
Sushmita D Lahiri, Robert A Giacobbe, Michele R Johnstone, et al.
The Journal of Antimicrobial Chemotherapy
|
July 13, 2016
Structural and sequence analysis of class A β-lactamases with respect to avibactam inhibition: impact of Ω-loop variations
Sushmita D Lahiri, Patricia A Bradford, Wright W Nichols, et al.
The Lancet. Microbe
|
March 30, 2026
WHO assessment of the preclinical antifungal pipeline: evaluating innovation and preparedness in the face of emerging fungal threats
Valeria Gigante, Richard A Alm, Tamarie Rocke, et al.
The Lancet. Microbe
|
October 25, 2024
Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses
Daniela Melchiorri, Tamarie Rocke, Richard A Alm, et al.
Microbiology (Reading, England)
|
November 13, 2002
Identification of strain-specific genes located outside the plasticity zone in nine clinical isolates of Helicobacter pylori
Grettel Chanto, Alessandra Occhialini, Nathalie Gras, et al.
The Journal of Antimicrobial Chemotherapy
|
June 6, 2015
Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline
Sushmita D Lahiri, Robert E McLaughlin, James D Whiteaker, et al.
Antimicrobial Agents and Chemotherapy
|
July 2, 2014
High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea
Susanne Jacobsson, Daniel Golparian, Richard A Alm, et al.
ACS Infectious Diseases
|
August 4, 2021
The CARB-X Portfolio of Nontraditional Antibacterial Products
Erin M Duffy, Ed T Buurman, Su L Chiang, et al.
The Journal of Antimicrobial Chemotherapy
|
April 30, 2014
Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective
Richard A Alm, Robert E McLaughlin, Veronica N Kos, et al.
The Journal of Antimicrobial Chemotherapy
|
November 2, 2017
Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model
Renu Singh, Mashal Almutairi, Richard A Alm, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
The Journal of Antimicrobial Chemotherapy
|
July 3, 2014
Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme
Sushmita D Lahiri, Robert A Giacobbe, Michele R Johnstone, et al.
The Journal of Antimicrobial Chemotherapy
|
July 13, 2016
Structural and sequence analysis of class A β-lactamases with respect to avibactam inhibition: impact of Ω-loop variations
Sushmita D Lahiri, Patricia A Bradford, Wright W Nichols, et al.
The Lancet. Microbe
|
March 30, 2026
WHO assessment of the preclinical antifungal pipeline: evaluating innovation and preparedness in the face of emerging fungal threats
Valeria Gigante, Richard A Alm, Tamarie Rocke, et al.
The Lancet. Microbe
|
October 25, 2024
Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses
Daniela Melchiorri, Tamarie Rocke, Richard A Alm, et al.
Microbiology (Reading, England)
|
November 13, 2002
Identification of strain-specific genes located outside the plasticity zone in nine clinical isolates of Helicobacter pylori
Grettel Chanto, Alessandra Occhialini, Nathalie Gras, et al.
The Journal of Antimicrobial Chemotherapy
|
June 6, 2015
Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline
Sushmita D Lahiri, Robert E McLaughlin, James D Whiteaker, et al.
Antimicrobial Agents and Chemotherapy
|
July 2, 2014
High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea
Susanne Jacobsson, Daniel Golparian, Richard A Alm, et al.
ACS Infectious Diseases
|
August 4, 2021
The CARB-X Portfolio of Nontraditional Antibacterial Products
Erin M Duffy, Ed T Buurman, Su L Chiang, et al.
The Journal of Antimicrobial Chemotherapy
|
April 30, 2014
Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective
Richard A Alm, Robert E McLaughlin, Veronica N Kos, et al.
The Journal of Antimicrobial Chemotherapy
|
November 2, 2017
Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model
Renu Singh, Mashal Almutairi, Richard A Alm, et al.
Page
of 5